Emerging Resistance in Chlamydia Requires Surveillance and Reassessment

نویسندگان
doi
10.18502/jmb.v13i4.20530
چکیده

Background: Chlamydia trachomatis remains one of the most common sexually transmitted infections (STIs) globally, often asymptomatic but capable of causing serious reproductive complications if left untreated. While azithromycin and doxycycline have traditionally been highly effective first-line treatments, recent evidence suggests a growing concern over reduced antibiotic efficacy and potential resistance.

کلیدواژه‌ها